With intramuscular (IM) injections the standard treatment for severe deficiency or malabsorption conditions like pernicious anaemiaserum B12 levels rise rapidly, typically reaching therapeutic ranges within 2448 hours after the first injection
These symptoms arise due to the bodys reduced ability to produce healthy red blood cells, leading to decreased oxygen supply to tissues
However, none of the studies reported on hematological or clinical outcomes
Improved Muscle Endurance Slu-pp-332 is investigated for its ability to improve exercise performance by upregulating oxidative muscle fibers and enhancing fatigue resistance
The RF energy enhances this process by delivering heat to deeper layers of the skin, tightening and firming from within
Research consistently shows low toxicity, minimal immunogenicity, and no significant adverse effects in controlled experimental conditions, supporting its suitability for scientific investigation rather than therapeutic application